The summer promises to be hot…
and you are among those unlucky ones who spend it at your desk?

Cheer up! BioFIT team has great news for you!

How to implement and perform effective Due Diligence?

3 experts already confirmed their presence in this thrilling session!

Scheduled December 2^nd at 2pm, the session will raise crucial questions going with the Due Diligence process. Due diligence is a complex analysis of the commercial, legal and financial data that needs to be well prepared, how can a biotech company best prepare for this process? How long does the process last? What are the expectations on pharma’s side?

To answer these questions, 3 top-notch speakers already confirmed their presence:

• Cécile Théard-Jallu, partner at De Gaulle Fleurance et Associés, will speak alongside
• Martin Cadman, scientific Licensing Director at GlaxoSmithKline and
• Carl Jessop, Due Diligence Director at AstraZeneca to address this complex topic!

We are already looking forward to attending this promising session!

Want to speak at BioFIT? Contact Ramona Pirv-Chicireanu, Conference Coordinator